Pediatrix Medical PE Ratio 2010-2023 | MD
Current and historical p/e ratio for Pediatrix Medical (MD) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pediatrix Medical PE ratio as of May 01, 2024 is 7.71.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pediatrix Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-01 | 9.01 | 0.00 | |
| 2023-12-31 | 9.30 | $-0.73 | 0.00 |
| 2023-09-30 | 12.71 | $1.13 | 11.25 |
| 2023-06-30 | 14.21 | $1.24 | 11.46 |
| 2023-03-31 | 14.91 | $1.22 | 12.22 |
| 2022-12-31 | 14.86 | $0.80 | 18.58 |
| 2022-09-30 | 16.51 | $0.99 | 16.68 |
| 2022-06-30 | 21.01 | $0.98 | 21.44 |
| 2022-03-31 | 23.48 | $1.07 | 21.94 |
| 2021-12-31 | 27.21 | $1.53 | 17.78 |
| 2021-09-30 | 28.43 | $0.22 | 129.23 |
| 2021-06-30 | 30.15 | $-0.63 | 0.00 |
| 2021-03-31 | 25.47 | $-9.07 | 0.00 |
| 2020-12-31 | 24.54 | $-9.51 | 0.00 |
| 2020-09-30 | 16.28 | $-8.64 | 0.00 |
| 2020-06-30 | 17.10 | $-23.39 | 0.00 |
| 2020-03-31 | 11.64 | $-15.46 | 0.00 |
| 2019-12-31 | 27.79 | $-18.04 | 0.00 |
| 2019-09-30 | 22.62 | $-17.47 | 0.00 |
| 2019-06-30 | 25.23 | $-1.51 | 0.00 |
| 2019-03-31 | 27.17 | $-0.56 | 0.00 |
| 2018-12-31 | 33.00 | $2.93 | 11.26 |
| 2018-09-30 | 46.66 | $3.71 | 12.58 |
| 2018-06-30 | 43.28 | $3.70 | 11.70 |
| 2018-03-31 | 55.63 | $3.54 | 15.71 |
| 2017-12-31 | 53.44 | $3.45 | 15.49 |
| 2017-09-30 | 43.12 | $2.83 | 15.24 |
| 2017-06-30 | 60.37 | $3.16 | 19.10 |
| 2017-03-31 | 69.38 | $3.36 | 20.65 |
| 2016-12-31 | 66.66 | $3.50 | 19.05 |
| 2016-09-30 | 66.25 | $3.65 | 18.15 |
| 2016-06-30 | 72.43 | $3.58 | 20.23 |
| 2016-03-31 | 64.62 | $3.59 | 18.00 |
| 2015-12-31 | 71.66 | $3.58 | 20.02 |
| 2015-09-30 | 76.79 | $3.48 | 22.07 |
| 2015-06-30 | 74.11 | $3.37 | 21.99 |
| 2015-03-31 | 72.51 | $3.26 | 22.24 |
| 2014-12-31 | 66.11 | $3.17 | 20.85 |
| 2014-09-30 | 54.82 | $3.06 | 17.92 |
| 2014-06-30 | 58.15 | $2.96 | 19.65 |
| 2014-03-31 | 61.98 | $2.86 | 21.71 |
| 2013-12-31 | 53.38 | $2.78 | 19.24 |
| 2013-09-30 | 50.20 | $2.66 | 18.91 |
| 2013-06-30 | 45.79 | $2.56 | 17.92 |
| 2013-03-31 | 44.82 | $2.48 | 18.07 |
| 2012-12-31 | 39.76 | $2.42 | 16.43 |
| 2012-09-30 | 37.23 | $2.36 | 15.81 |
| 2012-06-30 | 34.27 | $2.29 | 14.97 |
| 2012-03-31 | 37.19 | $2.26 | 16.49 |
| 2011-12-31 | 36.01 | $2.24 | 16.11 |
| 2011-09-30 | 31.32 | $2.20 | 14.24 |
| 2011-06-30 | 36.10 | $2.25 | 16.04 |
| 2011-03-31 | 33.31 | $2.20 | 15.17 |
| 2010-12-31 | 33.65 | $2.13 | 15.80 |
| 2010-09-30 | 26.65 | $2.11 | 12.66 |
| 2010-06-30 | 27.81 | $1.98 | 14.08 |
| 2010-03-31 | 29.10 | $1.92 | 15.15 |
| 2009-12-31 | 30.06 | $1.89 | 15.94 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.745B | $1.995B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.851B | 15.41 |
| Cencora (COR) | United States | $47.686B | 19.03 |
| ICON (ICLR) | Ireland | $24.574B | 23.20 |
| DiDi Global (DIDIY) | China | $24.011B | 0.00 |
| Avantor (AVTR) | United States | $16.459B | 24.23 |
| Viatris (VTRS) | United States | $13.776B | 3.96 |
| CochLear (CHEOY) | Australia | $13.705B | 0.00 |
| Revvity (RVTY) | United States | $12.658B | 22.18 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.086B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.032B | 39.59 |
| Charles River Laboratories (CRL) | United States | $11.796B | 21.50 |
| Natera (NTRA) | United States | $11.354B | 0.00 |
| Solventum (SOLV) | United States | $11.215B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| HealthEquity (HQY) | United States | $6.770B | 50.58 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 19.65 |
| Organon (OGN) | United States | $4.786B | 4.61 |
| Doximity (DOCS) | United States | $4.531B | 33.74 |
| PACS (PACS) | United States | $3.749B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.171B | 29.35 |
| Sotera Health (SHC) | United States | $3.170B | 15.56 |
| Progyny (PGNY) | United States | $3.081B | 51.71 |
| GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
| Life Times (LTH) | United States | $2.687B | 29.70 |
| Premier (PINC) | United States | $2.502B | 9.16 |
| AMN Healthcare Services Inc (AMN) | United States | $2.273B | 7.35 |
| Agilon Health (AGL) | United States | $2.261B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.162B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.830B | 0.00 |
| Agiliti (AGTI) | United States | $1.381B | 22.56 |
| Establishment Labs Holdings (ESTA) | $1.373B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.317B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.982B | 0.00 |
| Embecta (EMBC) | United States | $0.583B | 3.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Enhabit (EHAB) | United States | $0.506B | 45.86 |
| Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
| LifeMD (LFMD) | United States | $0.488B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.445B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.437B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| CareDx (CDNA) | United States | $0.402B | 0.00 |
| Beauty Health (SKIN) | United States | $0.399B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.379B | 0.00 |
| DocGo (DCGO) | United States | $0.352B | 56.33 |
| ModivCare (MODV) | United States | $0.333B | 4.42 |
| Ascend Wellness Holdings (AAWH) | United States | $0.304B | 0.00 |
| Sharecare (SHCR) | United States | $0.259B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.33 |
| Oncology Institute (TOI) | United States | $0.079B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |